Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 36 minutes ago
Back to Filings
FORM 144
AI

144 - November 25, 2024

Filed November 25, 2024
·
0002001011-24-000092

Rocket Lab officer Adam Spice files to sell 62,511 shares worth $1.5M to cover RSU taxes.

Brief

This Form 144 discloses Rocket Lab USA Inc. officer Adam C. Spice's intent to sell 62,511 common shares on 11/25/2024. Shares originated from 114,845 restricted stock units vesting on 11/22/2024 as compensation, with the sale covering tax obligations. Investors should note this routine insider transaction amid no prior 3-month sales.

Detailed Brief

Form 144 is a notice of proposed sale of restricted or control securities by affiliates under Rule 144 of the Securities Act of 1933, allowing public resale without registration after holding periods. Here, Rocket Lab USA Inc. (NASDAQ: RKLB) officer Adam C. Spice reports selling 62,511 common shares via Morgan Stanley, with an aggregate market value of $1,509,365.60 (implying ~$24.15/share). The shares stem from 114,845 RSUs vesting on 11/22/2024 as compensation from the issuer. No securities were sold by Spice in the prior 3 months, and the filing emphasizes the sale covers tax withholding from the vested award. Spice represents no undisclosed material adverse information. This fits Rocket Lab's pattern of executive equity incentives in the space industry, where stock-based compensation is common due to high growth and cash preservation needs.

Key Telemetry

  • Adam C. Spice, Rocket Lab officer, to sell 62,511 common shares on 11/25/2024.
  • Sale value: $1,509,365.60; shares outstanding: 503,928,615 (~0.012% of total).
  • Shares from 114,845 RSUs vesting 11/22/2024 as compensation.
  • Purpose: Cover tax obligations from vesting; no sales in past 3 months.

Impact Vector

This is a routine, non-discretionary insider sale to cover tax liabilities from RSU vesting, common for executives at growth companies like Rocket Lab. It signals no immediate concerns, as Spice affirms no undisclosed adverse info and has no recent sales. Investors should monitor aggregate insider activity and 10b5-1 plans for sentiment; minimal dilution or liquidity impact given scale vs. 504M shares outstanding. Watch Q4 earnings for compensation trends.

Search
Search across missions, customers, news, and SEC filings